Lista de obras - Emmanuelle Charafe-Jauffret

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

artículo científico publicado en 2013

Absence of ESR1 amplification in a series of breast cancers

scientific article published on 01 December 2008

BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells

artículo científico publicado en 2022

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.

artículo científico publicado en 2016

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

artículo científico publicado en 2009

Breast cancer stem cells programs: enter the (non)-code.

artículo científico publicado en 2016

Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts

scientific article published on 27 December 2013

Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome

artículo científico publicado en 2014

CD44 regulates epigenetic plasticity by mediating iron endocytosis

artículo científico publicado en 2020

Cancer stem cells in breast: current opinion and future challenges.

scientific article published on 10 June 2008

Chromosome arm 8p and cancer: a fragile hypothesis.

artículo científico publicado en 2003

Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture

artículo científico publicado en 2016

Comparative genomic analysis of primary tumors and metastases in breast cancer.

artículo científico publicado en 2016

Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers.

artículo científico publicado en 2016

Constitutive nuclear localization and initial cytoplasmic apoptotic activation of endogenous caspase-3 evidenced by confocal microscopy

artículo científico publicado en 2003

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.

artículo científico publicado en 2006

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

artículo científico publicado en 2016

Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling

artículo científico publicado en 2015

Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status.

artículo científico publicado en 2009

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.

artículo científico publicado en 2007

ETV6 gene rearrangements in invasive breast carcinoma

scientific article published on 01 September 2005

Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

artículo científico publicado en 2004

Gene expression profiling of breast cell lines identifies potential new basal markers.

artículo científico publicado en 2006

High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.

artículo científico publicado en 2012

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

artículo científico publicado en 2016

Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer

artículo científico publicado en 2016

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

artículo científico publicado en 2016

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.

artículo científico publicado en 2015

Integrated profiling of basal and luminal breast cancers.

artículo científico publicado en 2007

Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.

artículo científico publicado en 2016

Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer.

artículo científico publicado en 2003

Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.

artículo científico publicado en 2012

MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells.

artículo científico publicado en 2012

Moesin expression is a marker of basal breast carcinomas.

artículo científico publicado en 2007

Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data

artículo científico publicado en 2014

Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib.

artículo científico publicado en 2014

Prognosis and gene expression profiling of 20q13-amplified breast cancers

scientific article published on 01 August 2006

Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients.

artículo científico publicado en 2009

Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.

artículo científico publicado en 2008

The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression

artículo científico publicado en 2013

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

artículo científico publicado en 2005

What drives breast cancer heterogeneity: oncogenic events or cell of origin?

artículo científico publicado en 2012

[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].

artículo científico publicado en 2014

[Molecular entities of the breast cancer: the difference is in the origin]

artículo científico publicado en 2012

[Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France].

artículo científico publicado en 2014

[Stem cells and epithelial cancers: the example of breast cancer]

artículo científico publicado en 2008

[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].

artículo científico publicado en 2013

[ZNF703: a novel oncogene involved in breast cancer]

scientific article published on 28 April 2011

c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays

artículo científico publicado en 2007

p53 and cancer stem cells: The mevalonate connexion ⬇️

artículo científico publicado el 15 de julio de 2012

Lista de obras de Emmanuelle Charafe-Jauffret

ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.

Absence of ESR1 amplification in a series of breast cancers

BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells

Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

Breast cancer stem cells programs: enter the (non)-code.

Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts

Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome

CD44 regulates epigenetic plasticity by mediating iron endocytosis

Cancer stem cells in breast: current opinion and future challenges.

Chromosome arm 8p and cancer: a fragile hypothesis.

Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture

Comparative genomic analysis of primary tumors and metastases in breast cancer.

Consistency in recognizing microinvasion in breast carcinomas is improved by immunohistochemistry for myoepithelial markers.

Constitutive nuclear localization and initial cytoplasmic apoptotic activation of endogenous caspase-3 evidenced by confocal microscopy

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.

Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].

Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling

Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status.

ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.

ETV6 gene rearrangements in invasive breast carcinoma

Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

Gene expression profiling of breast cell lines identifies potential new basal markers.

High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.

Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation

Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer

Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation.

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study.

Integrated profiling of basal and luminal breast cancers.

Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.

Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer.

Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.

MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells.

Moesin expression is a marker of basal breast carcinomas.

Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data

Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparib.

Prognosis and gene expression profiling of 20q13-amplified breast cancers

Prognostic marker profile to assess risk in stage I-III hormone receptor-positive breast cancer patients.

Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.

The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

What drives breast cancer heterogeneity: oncogenic events or cell of origin?

[2014 update of the GEFPICS' recommendations for HER2 status determination in breast cancers in France].

[Molecular entities of the breast cancer: the difference is in the origin]

[Pre-analytical stage for biomarker assessment in breast cancer: 2014 update of the GEFPICS' guidelines in France].

[Stem cells and epithelial cancers: the example of breast cancer]

[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].

[ZNF703: a novel oncogene involved in breast cancer]

c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays

p53 and cancer stem cells: The mevalonate connexion ⬇️